Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The supplier has versions for subQ and IM injections
Merck Partners with Hansoh Pharma on Oral GLP-1 Receptor Agonist for Type 2 Diabetes Merck has entered into an exclusive global license agreement with Hansoh Pharma to develop and commercialize HS-10270, an investigational oral GLP-1 receptor agonist for the treatment of type 2 diabetes and obesity
sample (1,536) would have a margin of error of +/- 3.1 per cent, 19 times out of 20
Weight loss drugs generally do not qualify if used only to improve appearance, general health, or well-being
They found the molecule their GLP-1 journey was burning through.
US$ 29.88
US$ 29.00
US$ 27.35
US$ 29.62
US$ 27.33
